Company Spherix Inc Nasdaq
Equities
US84842R4039
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dominari Financial
100.0
%
| - | - | 2 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 2 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anthony Hayes
CEO | Chief Executive Officer | 56 | 01/13/01 |
Kyle Wool
PSD | President | - | 12/21/12 |
George M. Way
DFI | Director of Finance/CFO | - | 03/23/03 |
Chief Operating Officer | - | 01/22/01 | |
General Counsel | - | 01/23/01 | |
Darrell Dotson
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Ledwick
BRD | Director/Board Member | 66 | 09/15/09 |
Anthony Hayes
CEO | Chief Executive Officer | 56 | 01/13/01 |
Gregory Blattner
BRD | Director/Board Member | 47 | 03/18/03 |
Robert Dudley
BRD | Director/Board Member | 70 | 17/20/17 |
Kyle Wool
PSD | President | - | 12/21/12 |
Soo Yu
BRD | Director/Board Member | 53 | 07/22/07 |
Kyle Haug
BRD | Director/Board Member | 41 | 09/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,825 | 0 | 0 | 67.33 % |
Stock B | 0 | 834 | 0 | 0 | |
Stock C | 1 | 5,995,065 | 4,039,690 ( 67.38 %) | 60,148 ( 1.003 %) |
Company contact information
Dominari Holdings, Inc.
725 5th Avenue 23rd floor
10022, New York
+212-393-4540
http://www.aikidopharma.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+37.52% | 3.88TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr |